Variant Of Concern

India recorded 752 new COVID-19 cases in the last 24 hours amid concerns over a new variant driving the latest surge in infections. Four related death were also reported during this period.

Kerala Health Minister Veena George on Sunday said the Covid-19 sub-variant JN.1 that has been detected in the state was not a cause for concern.

The UK health authorities began rolling out their winter vaccine schedule for the most medically vulnerable on Monday, brought forward from a planned early October rollout amid concerns around the new COVID variant BA.2.86.

2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.

The BF.7 variant is highly transmissible and has a shorter incubation period - the time between catching the virus and beginning to have symptoms of the disease.

The tsunami of Covid-19 that's taking hold across China is spurring concern that a dangerous new virus variant could emerge for the first time in more than a year, just as genetic sequencing to catch such a threat is dwindling.

The tsunami of Covid-19 that's taking hold across China is spurring concern that a dangerous new variant could emerge for the first time in more than a year, just as genetic sequencing to catch such a threat is dwindling.

The Health Ministry today directed states and union territories to ramp up surveillance amid a rise in Covid cases worldwide. A surge of new Covid cases in China has spurred concern that a dangerous new variant could emerge.

No new variant of concern of coronavirus has been detected in India since Omicron in the first week of December 2021 according to the Indian SARS-CoV-2 Genomics Consortium, the Lok Sabha was informed Friday.

Be prepared for fresh COVID-19 waves, WHO chief scientist Soumya Swaminathan has warned, amid the onset of new variants that are more transmissible, immune evasive and growing concerns about greater hospitalisations.

A new sub-lineage BA.2.75 of the Omicron variant of the coronavirus has been detected in countries like India and the World Health Organisation is following this, Director-General Tedros Adhanom Ghebreyesus said.

The increase in the number of COVID-19 cases in the country over the last few days should not be a cause for panic, health experts said on Saturday, highlighting that no new variant of concern has been found.

Panic does not serve as a COVID pandemic response or public health response as it does not help analyse the data, therefore, panic doesn't serve any purpose, said Samiran Panda, Additional director-general of Indian Council of Medical Research said.

A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.

An inhaled form of COVID-19 vaccine developed by scientists at McMaster University in Canada can provide broad, long-lasting protection against the SARS-CoV-2 variants of concern, a preclinical study has found

India recorded 752 new COVID-19 cases in the last 24 hours amid concerns over a new variant driving the latest surge in infections. Four related death were also reported during this period.

Kerala Health Minister Veena George on Sunday said the Covid-19 sub-variant JN.1 that has been detected in the state was not a cause for concern.

The UK health authorities began rolling out their winter vaccine schedule for the most medically vulnerable on Monday, brought forward from a planned early October rollout amid concerns around the new COVID variant BA.2.86.

2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.

The BF.7 variant is highly transmissible and has a shorter incubation period - the time between catching the virus and beginning to have symptoms of the disease.

The tsunami of Covid-19 that's taking hold across China is spurring concern that a dangerous new virus variant could emerge for the first time in more than a year, just as genetic sequencing to catch such a threat is dwindling.

The tsunami of Covid-19 that's taking hold across China is spurring concern that a dangerous new variant could emerge for the first time in more than a year, just as genetic sequencing to catch such a threat is dwindling.

The Health Ministry today directed states and union territories to ramp up surveillance amid a rise in Covid cases worldwide. A surge of new Covid cases in China has spurred concern that a dangerous new variant could emerge.

No new variant of concern of coronavirus has been detected in India since Omicron in the first week of December 2021 according to the Indian SARS-CoV-2 Genomics Consortium, the Lok Sabha was informed Friday.

Be prepared for fresh COVID-19 waves, WHO chief scientist Soumya Swaminathan has warned, amid the onset of new variants that are more transmissible, immune evasive and growing concerns about greater hospitalisations.

A new sub-lineage BA.2.75 of the Omicron variant of the coronavirus has been detected in countries like India and the World Health Organisation is following this, Director-General Tedros Adhanom Ghebreyesus said.

The increase in the number of COVID-19 cases in the country over the last few days should not be a cause for panic, health experts said on Saturday, highlighting that no new variant of concern has been found.

Panic does not serve as a COVID pandemic response or public health response as it does not help analyse the data, therefore, panic doesn't serve any purpose, said Samiran Panda, Additional director-general of Indian Council of Medical Research said.

A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.

An inhaled form of COVID-19 vaccine developed by scientists at McMaster University in Canada can provide broad, long-lasting protection against the SARS-CoV-2 variants of concern, a preclinical study has found